It's Time to rethink flu

FLUCELVAX Important Safety Information READ MORE

What is FLUCELVAX?

FLUCELVAX is a vaccine that helps protect against influenza (flu). FLUCELVAX is for people aged 18 and older. Vaccination with FLUCELVAX may not protect all people who receive the vaccine.

Important Safety Information for FLUCELVAX

Who should not get FLUCELVAX? You should not get FLUCELVAX if you have had a severe reaction to any of the ingredients in the vaccine.

Introducing

It was the first breakthrough in flu vaccine

production technology in over 40 years.1

Scroll down to see how FLUCELVAX can

help you rethink flu.

Cell Culture Technology

Cell Culture
Technology

FLUCELVAX Influenza Virus Vaccine is made with advanced cell culture technology in closed bioreactors, eliminating the need for antibiotics.

keep moving

Keep Moving

Don't let the flu slow you down. Help protect yourself from the flu with FLUCELVAX Influenza Virus Vaccine.

Ready to Use

FLUCELVAX Influenza Virus Vaccine comes in pre-filled syringes, it is 100% free of preservatives and antibiotics.

Proven Effective

Proven Effective

FLUCELVAX Influenza Virus Vaccine is clinically proven to have a similar safety and efficacy profile as conventional trivalent influenza vaccines.2

Rethink Flu

FLUCELVAX Influenza Virus Vaccine was the first flu vaccine approved by the FDA to use cell culture technology3. It does not contain antibiotics or preservatives. FLUCELVAX is an alternative vaccine choice to help prevent the flu.

Ask your healthcare provider about FLUCELVAX.

Social Flu Tracker

See Outbreaks this year in:

The World's First
Socially Enabled Flu Tracker

The Social Flu Tracker is the world's first socially driven flu tracker using social media to monitor the chatter about the flu virus in real time. The map is tracking hashtags such as #flu #fluseason #fluvirus and others in social conversations in the United States and plotting them on the map according to where the chatter is started.

Join the Conversation with a tweet

Outbreaks this Year

  • Widespread
  • Regional
  • Localized
  • Sporadic
  • Out Of Season
    Jul
  • Out Of Season
    Aug
  • Sep
  • Oct
  • Nov
  • Dec
  • Jan
  • Feb
  • Mar
  • Apr
  • May
  • Out Of Season
    Jun
Content Source: Center For Disease Control (CDC)
Source: Compiled from monitoring social media sites over the past 24 hours. This data is not meant to be an accurate indicator of the spread of the influenza virus.

FLUCELVAX Important Safety Information

What is FLUCELVAX?

FLUCELVAX is a vaccine that helps protect against influenza (flu). FLUCELVAX is for people aged 18 and older. Vaccination with FLUCELVAX may not protect all people who receive the vaccine.

Who should not get FLUCELVAX?

You should not get FLUCELVAX if you have had a severe allergic reaction to any of the ingredients in the vaccine.

Who may not be able to get FLUCELVAX?
Tell your healthcare provider if you:
  • have ever had Guillain-Barré Syndrome (severe muscle weakness) after getting a flu shot
  • have an allergy to rubber latex
What if I have a weakened immune system?

Tell your healthcare provider if you have problems with your immune system, as your immune response to the vaccine may be less.

What are the most common side effects of FLUCELVAX?
  • pain or redness where you got the shot
  • headache
  • tiredness
  • muscle aches
  • feeling unwell (malaise)

These are not all of the possible side effects of FLUCELVAX. You can ask your healthcare provider for a complete list of possible side effects.

Ask your healthcare provider for advice about any side effects that concern you. You may report side effects to the Vaccine Adverse Events Reporting System (VAERS) by calling 1-800-822-7967 or by going to http://vaers.hhs.gov.

To report SUSPECTED ADVERSE REACTIONS, contact Novartis Vaccines at 1-877-683-4732 or VAERS at 1-800-822-7967 and http://vaers.hhs.gov.

Please see accompanying US Full Prescribing Information for FLUCELVAX.

References

1. Center for Infectious Disease Research & Policy. The compelling need for game-changing influenza vaccines: an analysis of the influenza vaccine enterprise and recommendations for the future. www.cidrap.umn.edu/cidrap/files/80/ccivi%20report.pdf. Published October 2012. Accessed June 18, 2014.

2. FLUCELVAX [package insert]. Cambridge, MA: Novartis Vaccines and Diagnostics, Inc; 2014.

3. FDA approves first seasonal influenza vaccine manufactured using cell culture technology [news release]. Silver Spring, MD: U.S. Food and Drug Administration; November 20, 2012.

  • Rethink Flu
  • Introducing FLUCELVAX
  • Cell Culture Technology
  • Keep Moving
  • Ready to Use
  • Proven Effective
  • Rethink Flu
  • Social Flu Tracker